Received: from MW6PR01MB8222.prod.exchangelabs.com (2603:10b6:303:24a::12) by
 BN0PR01MB7134.prod.exchangelabs.com with HTTPS; Fri, 3 Nov 2023 12:38:03
 +0000
Received: from DS7PR05CA0103.namprd05.prod.outlook.com (2603:10b6:8:56::18) by
 MW6PR01MB8222.prod.exchangelabs.com (2603:10b6:303:24a::12) with Microsoft
 SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id
 15.20.6954.21; Fri, 3 Nov 2023 12:38:01 +0000
Received: from CY4PEPF0000EE34.namprd05.prod.outlook.com
 (2603:10b6:8:56:cafe::c8) by DS7PR05CA0103.outlook.office365.com
 (2603:10b6:8:56::18) with Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.6977.10 via Frontend
 Transport; Fri, 3 Nov 2023 12:38:01 +0000
Authentication-Results: spf=fail (sender IP is 18.7.71.112)
 smtp.mailfrom=em3433.checkin.medical.mit.edu; dkim=pass (signature was
 verified) header.d=checkin.medical.mit.edu;dmarc=pass action=none
 header.from=checkin.medical.mit.edu;
Received-SPF: Fail (protection.outlook.com: domain of
 em3433.checkin.medical.mit.edu does not designate 18.7.71.112 as permitted
 sender) receiver=protection.outlook.com; client-ip=18.7.71.112;
 helo=mail.exchange.mit.edu;
Received: from mail.exchange.mit.edu (18.7.71.112) by
 CY4PEPF0000EE34.mail.protection.outlook.com (10.167.242.40) with Microsoft
 SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_CBC_SHA384) id
 15.20.6954.19 via Frontend Transport; Fri, 3 Nov 2023 12:38:00 +0000
Received: from oc11expo11.exchange.mit.edu (18.9.4.16) by
 w92exhyb7.exchange.mit.edu (18.7.71.112) with Microsoft SMTP Server (TLS) id
 15.0.1497.48; Fri, 3 Nov 2023 08:37:48 -0400
Received: from oc11exhyb2.exchange.mit.edu (18.9.1.98) by
 oc11expo11.exchange.mit.edu (18.9.4.16) with Microsoft SMTP Server (TLS) id
 15.0.1497.42; Fri, 3 Nov 2023 08:37:48 -0400
Received: from NAM04-MW2-obe.outbound.protection.outlook.com (104.47.73.168)
 by oc11exhyb2.exchange.mit.edu (18.9.1.98) with Microsoft SMTP Server (TLS)
 id 15.0.1497.48 via Frontend Transport; Fri, 3 Nov 2023 08:37:48 -0400
Received: from SA9PR11CA0026.namprd11.prod.outlook.com (2603:10b6:806:6e::31)
 by BN0PR01MB7166.prod.exchangelabs.com (2603:10b6:408:155::20) with Microsoft
 SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id
 15.20.6954.21; Fri, 3 Nov 2023 12:37:41 +0000
Received: from SA2PEPF000015C6.namprd03.prod.outlook.com
 (2603:10b6:806:6e:cafe::d3) by SA9PR11CA0026.outlook.office365.com
 (2603:10b6:806:6e::31) with Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.6954.21 via Frontend
 Transport; Fri, 3 Nov 2023 12:37:41 +0000
Authentication-Results-Original: spf=pass (sender IP is 149.72.180.222)
 smtp.mailfrom=em3433.checkin.medical.mit.edu; dkim=pass (signature was
 verified) header.d=checkin.medical.mit.edu;dmarc=pass action=none
 header.from=checkin.medical.mit.edu;compauth=pass reason=100
Received-SPF: Pass (protection.outlook.com: domain of
 em3433.checkin.medical.mit.edu designates 149.72.180.222 as permitted sender)
 receiver=protection.outlook.com; client-ip=149.72.180.222;
 helo=wrqvbqdz.outbound-mail.sendgrid.net; pr=C
Received: from wrqvbqdz.outbound-mail.sendgrid.net (149.72.180.222) by
 SA2PEPF000015C6.mail.protection.outlook.com (10.167.241.196) with Microsoft
 SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id
 15.20.6954.19 via Frontend Transport; Fri, 3 Nov 2023 12:37:40 +0000
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=checkin.medical.mit.edu;
	h=content-transfer-encoding:content-type:from:mime-version:subject:to:
	cc:content-type:from:subject:to;
	s=s1; bh=5xv9J9BI4XQjzXPSsJy/iGB1NoYULIq4s33jBWOa/mQ=;
	b=ArEG3RV84QXQYZP/SB6BhpKG19vZ3FQ/0RzVpOLzXeHQvB4fHaLbWEDJxdJigb5R54rk
	JWdahjUJ/0puSXB4qBVr8wE++3FvE10Y/bUWFq6S+KQaMT0jfQKEqLVCX7qWmDZnTpF69u
	IFvj2OF3ZKnRFGZwBk6+62fm9Q8LmQ5+5a3dl43hgH5hcp1g7MhDkUfpnOkDWnVdXuKz/P
	rukF3K3s93PqzuuYfTo0Fc2JEpSTXWi6OPefTa7sFRNVr/d04ksI0dohI8G/cJW8VZPguP
	MPcboOuMNHqlTxybfCrYECYMHNC2mr65V724/PiT2bmVCCKZUoFNAtB06CeQly2g==
Received: by filterdrecv-54fb999b49-4xbrd with SMTP id filterdrecv-54fb999b49-4xbrd-1-6544E994-3A
        2023-11-03 12:37:40.257198268 +0000 UTC m=+1446960.150759690
Received: from MTYxMDY4MzA (unknown)
	by geopod-ismtpd-4 (SG) with HTTP
	id keUfDMYLRMO4QBA-_g3gbw
	Fri, 03 Nov 2023 12:37:40.190 +0000 (UTC)
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset=utf-8
Date: Fri, 3 Nov 2023 12:37:40 +0000
From: MIT Medical <noreply@checkin.medical.mit.edu>
Message-ID: <keUfDMYLRMO4QBA-_g3gbw@geopod-ismtpd-4>
Subject: Still need your COVID-19 vaccine?
X-SG-EID: =?us-ascii?Q?XS8BCwX4z=2F1XtKs2N5HJaC+bMsY43DUXNdEQ49ZJ=2F1NkfAVCQrJwMdpvWHn43W?=
 =?us-ascii?Q?pm9hCiTqd6Roh4QNHDr0K8SX7ItjRGaR9nsKkX8?=
 =?us-ascii?Q?DCtzXEqeN=2FKrK7=2FPy8ZverqAPHMEPMaxP4EUhB3?=
 =?us-ascii?Q?SVSw09ga7G7lIr+xtwxD6db0iJSjLPcvUupt2HZ?=
 =?us-ascii?Q?MVfYIPnWcuKDYRIpTOBYkg3txBjS20yp6+43N3x?=
 =?us-ascii?Q?6jj5AIdxyhVrWFPtb4diQ9fnCD1z=2F4AxbdzSEJ?=
To: Jiannan <jiannan@MIT.EDU>
X-Entity-ID: z15nbEf53RE5RFJCKrth0w==
Return-Path:
 bounces+16106830-aa68-jiannan=mit.edu@em3433.checkin.medical.mit.edu
X-EOPAttributedMessage: 1
X-MS-TrafficTypeDiagnostic:
 SA2PEPF000015C6:EE_|BN0PR01MB7166:EE_|CY4PEPF0000EE34:EE_|MW6PR01MB8222:EE_|BN0PR01MB7134:EE_
X-MS-Office365-Filtering-Correlation-Id: 23506403-ea50-44ff-dceb-08dbdc69b767
X-MS-Exchange-AtpMessageProperties: SA
X-Microsoft-Antispam-Untrusted: BCL:4;
X-Microsoft-Antispam-Message-Info-Original:
 =?utf-8?B?RDc4NEJ4OC92NUU1UHM1cHJvQnNya0RJajRZeGxGVW9NK2J5aW9QcmQ2bDN6?=
 =?utf-8?B?RTdCMzRiTmRENFU1NmlMdGdUaERpcGNNUU1oQ3FYZ0dBZ29wNG9wRUZnZXpW?=
 =?utf-8?B?eVJtTHF3SVB0S25nY3R6UTB5SEJTbGNBMVF4NGRzVll5SW9ubmtZWnFaKyt2?=
 =?utf-8?B?R0ZYMytodjJHV3dVM2VCQi9OS1E4b09PR3Q2UTgzY3U0ZmxHeVZadUkxb21J?=
 =?utf-8?B?VXVDQitLRk5VYmlKcUk0QzR2NVV5YjJCRFNueVRwQzRyK2xrbTNtR01VS25B?=
 =?utf-8?B?bGdGV2xnclFKSHhjN1ZFTmU1cG9jVXV4bE51Qlg2RHRSV1B2blJITVhaY1Bv?=
 =?utf-8?B?Wk1pbDlwRmUvSkczSEtqbVFmNUJxSXR6M0Z4Wk1PeGViYzE3MVN6a0trWFlx?=
 =?utf-8?B?cjdFYjZCdFVlWlpkUWsxMUhUcFRhZFZhbTBhbWdCajNmVjVRbHpBcVZ6WXdW?=
 =?utf-8?B?SEYrUnJxWEtDeGlxNkc3UXBGYU9jYkVIVGJTanU1QmlwUm9yc05Nek1tT0h2?=
 =?utf-8?B?azhHOUlYTzhaRkF0bmZmb0hSYTdFemZNK0lOT3FiVGVIUHd6TzE0TWVPWWpP?=
 =?utf-8?B?MjNXT0RhQVI3KzFPWmozaStzWStDV090Yk5mcE9lMzd6VzNFNXdKcTY2TDg3?=
 =?utf-8?B?T3NtakJYd0ZyeENXZ0pQVW40UncwMlJJYmtycGFwMXV4cm1qNWpDTVp1T3ZI?=
 =?utf-8?B?Q2NHSm4yS2x6QXZ5ckVFaHk3WE1HVE13SCtaV2ZMRk05b2hrNU9FM3VWNW4y?=
 =?utf-8?B?SlBBYUZJc0VudHBsRTkrUGpjc2FMNitFMGdJa0hDMzF2OVZvOWtwajl4UFJl?=
 =?utf-8?B?UUR1TGtodEJNSXpqSXJ3ZHQreGtYcmJDUTAwMlFoVkRueUxEbXZRTTdpUkln?=
 =?utf-8?B?bjBOUnQreUI5Y1hYL24zbGJOWVh2UHg5WWtwdk8yWDVObnZmeGFBbjVUMVFR?=
 =?utf-8?B?QlFRU3JJL2FVNlh2UXdjbGQvNmlKdXllVS9HUFJoOHJNU1JnSXY5czdlWWpH?=
 =?utf-8?B?N2poTWVMMXBJYzNvOFdQc0hQbVAxTnRrODBsYjZvWmRZMGZVUEJjMXZtek51?=
 =?utf-8?B?NkpEanY2dmJqVE9sQlpGVDZyMG1rZW1PNm12alZIZExTRStVeUdTaW9SR1NX?=
 =?utf-8?B?cU5PMEVHN0x3Rk5NRVp4bmZPaUVZbmhFMFdZYmlMZm1CaCtIaDJMdWd2eHRr?=
 =?utf-8?B?WTJZeUt5Si9UOW90VG9tNE1NRGd5K3lGTjN6VElTMURWdFRxcVJvSmZMMlNE?=
 =?utf-8?B?dmt0a01jRzdUb1UzQ0lWNlFtRlUyUlFQNWpvZXBDU0ROajdGUDRZZE5pYTFj?=
 =?utf-8?B?c1k0Lzh1TDRmWUZ0aUxrM2Vic3ZueWFRWUx5TytzcDI4VExHUnRsRlNlWnJK?=
 =?utf-8?B?clNzVXV3V2dUNVV0MnFLbVFaQ2M3a29WUm1ydW1paEJxdWZDYmJSNG0vb09W?=
 =?utf-8?B?K2ZOdXpsME82QUpIVFAzQVA1bkhvMktnTWQwQnZoaFhRUGZla09BUDQrdlpy?=
 =?utf-8?B?YTRYRlhSWGtWQWl3RjVYbEFmMzZUZDErbkh1aW5RanA0VDlLU2QxWEdWVUxl?=
 =?utf-8?B?dmwrZTdRTVlTMFRZYW14ZHBDTk1uaEV0d3BvcEYwWnRpb3FUd2JDMFFjZ2JT?=
 =?utf-8?B?WFEzU3l1czljMVRpRlhLOXBzNUpmQ0paOWVZb2RZUmV5S3F0YmJDZzVKd2FM?=
 =?utf-8?B?Wnc1YTdFdndLR3ltZDhURjZXS2RRVzdxcS9WVG9VRkV6U0h1cUQ4dzNuMGR3?=
 =?utf-8?B?ZEJMS2VkNjVsQTdaSmZ3MElLbmU2NDREUzlrVEdYWlZmYlBWSEZCRGlIdjZ4?=
 =?utf-8?B?b3NRdzZDZGpwV2h4N2dGNW14REl3b2pGRXJWTWhRdFhrdTFHWlVkSk5XTEhZ?=
 =?utf-8?B?VVkxcXlJUyttQm9yUlFLMUx1NzEvZ1VBSE5YWHhnWm1IdVZlUXBxN29EM2cx?=
 =?utf-8?B?OFNFUlZzRlZmdDdqT2F3aHQ3eG0wVzU4UVNsVjhnc25HSjhWL084UGgzR1R5?=
 =?utf-8?B?czlTbDZYOGF5UHZMY2I2aUZKdVlMUTRXdUljVVJMemxJZDlLYzh3SUVVT2py?=
 =?utf-8?B?MzN5QmR5MWVvakJSUGs0L3FxZ1RxZlcxd3c3NDZnKy94bGdPMlpUZWdXMHFN?=
 =?utf-8?B?US9HRFRLUWw1MVBXWWtNTDJvZU5IZHhUQVVEcjFzNXp1VlJZZTd3b3FrK05x?=
 =?utf-8?B?ZXFTN1NCbnEwRCt0Qkp6NzBiR0xjbkZ5cC9mbFNmY2N3QVd5UTg5bE8zZ21v?=
 =?utf-8?B?OTd6MDhjTlBpRDNMYVBVclJJNUorY3B0SytvcXlEVVVXQyt2anVLMGhwM0lp?=
 =?utf-8?Q?hicjTlw9dXCarWtMYJ?=
X-Forefront-Antispam-Report-Untrusted:
 CIP:149.72.180.222;CTRY:US;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:wrqvbqdz.outbound-mail.sendgrid.net;PTR:wrqvbqdz.outbound-mail.sendgrid.net;CAT:NONE;SFS:(13230031)(7916004)(4636009)(286005)(451199024)(558084003)(4006050)(75432002)(33716001)(9316004)(6486002)(336012)(356005)(83170400001)(7636003)(7596003)(9686003)(6512007)(58800400005)(6506007)(26005)(6916009)(36736006)(1096003)(8676002)(75640400001);DIR:INB;
X-MS-Exchange-Transport-CrossTenantHeadersStamped: BN0PR01MB7166
X-OrganizationHeadersPreserved: BN0PR01MB7166.prod.exchangelabs.com
X-CrossPremisesHeadersPromoted: oc11exhyb2.exchange.mit.edu
X-CrossPremisesHeadersFiltered: oc11exhyb2.exchange.mit.edu
X-OrganizationHeadersPreserved: oc11expo11.exchange.mit.edu
X-MS-Exchange-Organization-ExpirationStartTime: 03 Nov 2023 12:38:00.9771
 (UTC)
X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit
X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000
X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit
X-MS-Exchange-Organization-Network-Message-Id:
 23506403-ea50-44ff-dceb-08dbdc69b767
X-MS-Exchange-Organization-MessageDirectionality: Originating
X-MS-Exchange-Organization-SCL: 1
X-CrossPremisesHeadersPromoted: CY4PEPF0000EE34.namprd05.prod.outlook.com
X-CrossPremisesHeadersFiltered: CY4PEPF0000EE34.namprd05.prod.outlook.com
X-MS-Exchange-Transport-CrossTenantHeadersStripped:
 CY4PEPF0000EE34.namprd05.prod.outlook.com
X-MS-PublicTrafficType: Email
X-MS-Exchange-Organization-AuthSource:
 SA2PEPF000015C6.namprd03.prod.outlook.com
X-MS-Exchange-Organization-AuthAs: Anonymous
X-OriginatorOrg: exchange.mit.edu
X-MS-Office365-Filtering-Correlation-Id-Prvs:
 c805f371-6b5c-47b7-7f78-08dbdc69ab7d
X-Microsoft-Antispam: BCL:4;
X-Forefront-Antispam-Report:
 CIP:18.7.71.112;CTRY:US;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:mail.exchange.mit.edu;PTR:w92exhyb7.exchange.mit.edu;CAT:NONE;SFS:;DIR:INB;
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 03 Nov 2023 12:38:00.7271
 (UTC)
X-MS-Exchange-CrossTenant-Network-Message-Id: 23506403-ea50-44ff-dceb-08dbdc69b767
X-MS-Exchange-CrossTenant-Id: 64afd9ba-0ecf-4acf-bc36-935f6235ba8b
X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=64afd9ba-0ecf-4acf-bc36-935f6235ba8b;Ip=[18.7.71.112];Helo=[mail.exchange.mit.edu]
X-MS-Exchange-CrossTenant-AuthSource:
 SA2PEPF000015C6.namprd03.prod.outlook.com
X-MS-Exchange-CrossTenant-AuthAs: Anonymous
X-MS-Exchange-CrossTenant-FromEntityHeader: HybridOnPrem
X-MS-Exchange-Transport-CrossTenantHeadersStamped: MW6PR01MB8222
X-MS-Exchange-Transport-EndToEndLatency: 00:00:02.2876414
X-MS-Exchange-Processed-By-BccFoldering: 15.20.6954.021
X-Microsoft-Antispam-Mailbox-Delivery:
	ucf:0;jmr:0;auth:0;dest:I;ENG:(910001)(944506478)(944626604)(920097)(930097)(140003);
X-Microsoft-Antispam-Message-Info:
	=?utf-8?B?bVp1aGtPQUFCVVM0WklxYzhrS1FCL1UzT1ZYdkp4WGlpVFhFKzFNQzQzbGFL?=
 =?utf-8?B?VTU4Um9OUnNhTndXS3JjWnJpQmw0SFhIOUQ3bVpyRVRjOWlrZnNJTENHMUpv?=
 =?utf-8?B?NXBTRVIvSHhJdWRZTkp5b1JUYmxqQThRclBzSGdGM1hJbEZaRm03MlF2a2d1?=
 =?utf-8?B?b3A3OG93SndyWEIva1BGQklQU09ENVBxVmtuMzY5cUI0di8yY3ZFQjcvTGI3?=
 =?utf-8?B?OGpqcE1TZklWMTA2MUtxNVdDOXQyMDNsanVjTUZCVmZtSUZzYlk3eDlGdWpI?=
 =?utf-8?B?T1BIdFlxWWdWSWpySTl5NkJncktKSzZzVGZlODc0c2pWQXhLelp3ajRWOWhQ?=
 =?utf-8?B?VnF3ZERmZGFoSVF2c0JJU2diWnlkbkJLa01uWTd3VHhia3Ricm1pUkcwRzR2?=
 =?utf-8?B?dCtuQXVVNG1GdE5NQVhkQVRadVhQa0dzK0U4RDBGWnNyR1gxTHhZdzhZZXJP?=
 =?utf-8?B?eXQ4akk5M0pwU2FVcGxiU3BsN3dTUXBUVFltNTd6MHJFYWxXaU9MdkFuSTVw?=
 =?utf-8?B?a0lpUjd2LzhDc24raVZEcEgrWmJPNmord1RhVEdzc1pmeXNvOUVDdEJjSjJ1?=
 =?utf-8?B?ejI2cWp4TGpzVWlRWjFFUUExcVo2YjVmbC9Nc1owUmNXVnBkL1VkUWV5OURU?=
 =?utf-8?B?NWcvVWpOQXpJQjNpd0pZWE5CbFpHMC9kYzJhRkNBTjVMRkswMitQeUVkbEVo?=
 =?utf-8?B?bTlZWW1oajlYSVhBbmZhNTdWTDh5Y1krWEUzMkRZY21MR2FXYXBwbXZ1cWRH?=
 =?utf-8?B?dDdDYXZLN00va0xYMWRFRHBzVXZNN2NVOWxWMnZQNXF0cHQrYTVNdlZaVy96?=
 =?utf-8?B?Vys0TzlsUklxWEpDYWxFcmlCN2pEaysrbnpvRGw4SmdFdUNVeWJOam9EZVE3?=
 =?utf-8?B?Zk1zaFNhYmE2UE1WalpnT3J3QTUvT3JqL25qQ1A3ZVRGNDJSRVY5a2c3eFdy?=
 =?utf-8?B?WGlVUXhMVWVTTDBZUkVtekxkam02bXFNR085WHVrQlpqZkV1R0JObkIyb2l3?=
 =?utf-8?B?RC9GQlNWVTY1Z2tVb1VFcDNmTm44enlYWkpTUE9HUzVURjRxR3dpN0FyU2Mr?=
 =?utf-8?B?VkRMRHpYNHhMRndSQS83Q0VIcTZkR0I5b2YzalluRW9sZWJ2ckJiK0RwRXNV?=
 =?utf-8?B?bWRMMUFRV1pNdlNyVDhaekFtTHB4NEl0L2I2OUJZSkhyUUpWNmFTcnZPSlRM?=
 =?utf-8?B?VndCeU9WblAyaVE2c1ovd1FWVk1uTVZBVUJlTXk4anNqMHJsNmM5dFVOTGts?=
 =?utf-8?B?eE5OZXNQemxZekRSYkdrN0ZuMnBMNlBYbGlMcVlINFo5dGEyeDAzT1AzRSts?=
 =?utf-8?B?eWM1aEFPU09RYVc4UHROWnQ2eUsxQ25DQ0pGSFNodUh2QkxpWlJlaFYxOGhC?=
 =?utf-8?B?R2pxaURPQWJTSk9idS9odkd1ZWR3SnJTM1RxMFp3UVNPejh4VHNVTXgwaEFh?=
 =?utf-8?B?a1U5a0I2MzlOZG5PdVFhQ3pmQ3FzalNINjZxVUM5TlZ6UWo1QnlyeStOWVBk?=
 =?utf-8?B?Z0hnenMxOXBVbWNCMjE0em84T3Z1djVOVjNueDR6OFZKT2hyYmtSbnZPNVk3?=
 =?utf-8?B?eTFMM3NuUFpDK0VhMGQ5Z2kvcTdqVXRMZzZqNTVYUk5JdEJCR3BPUlY5WlMw?=
 =?utf-8?B?SGdZaXF5cTlGVFdDWUR4L2JRS2orclJQRnFPSklCNmhqSFlJckkxVlhjbW93?=
 =?utf-8?B?ZUNqN0p2VmxpZ1A5RjFEbVJhcFN5aGNVbm9Pd1J5L1AxNnVuREV5UFV5ek9p?=
 =?utf-8?B?N3hqVEJSb0xVbkc5ejBiSFF0aXJHWENFbm5FN2NQdXBPK2wyWHdRbHNKSkFB?=
 =?utf-8?B?eFQxOVM4cUtNeTBYOS96MG1SSmdOSnJRazZ6M2o4dnFCVkNXZW8vVFhMWTc0?=
 =?utf-8?B?bzhvMWxvcVNUbkFibjJLL0tXdys0WStIZmtGQWJhUFYrWEl2YkRad0hCMUMv?=
 =?utf-8?B?Y3l6YWlYZ2owWHB2UmNQK0NJYXFsSU9aZWgyL3NFSS9DWUxaSXFBWWZVSmND?=
 =?utf-8?B?N1Y3MWlRUUZBcW51Y3dROGthOHo0Q1hDL2tHdlgyLzJzd1ZoSmxERkp0NDJi?=
 =?utf-8?B?YzhZWXZCd1dPL05nOHg0ampvdzhyeXFLSGxkUnFBSE9kS01hMTluR3NhZWdt?=
 =?utf-8?B?Nkt1M05mL3pPY1lxdnVoMWNpRU9wODJLa3dMLzBicXBEaGdPWkswWllyUExs?=
 =?utf-8?B?bk4yR0Z2R3l0WEdqMHFOeTgwQ3h4T0JOZXhyVmFaeC9WOU5mQjUwWGlzcjVJ?=
 =?utf-8?B?dXIyNHhqbFA3L01UQm95dWhEa0wzbEZvQ3ZmQkdqSTc0dTEvckpEQWdZR2FP?=
 =?utf-8?Q?uNkS/zlLF1fBSHg2pk?=
MIME-Version: 1.0

<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3Dutf-8">MI=
T Medical has 200 remaining Pfizer COVID-19 vaccines available today (Novem=
ber 3) from 10 a.m. =E2=80=93 2 p.m. in E-23 Room 009. No appointment is ne=
eded. The vaccines are first-come-first-serve.
